These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 22899340)

  • 101. CD21/CD35 in B cell activation.
    Carroll MC
    Semin Immunol; 1998 Aug; 10(4):279-86. PubMed ID: 9695184
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Enhanced CD21 expression and shedding in chronic lymphatic leukemia: a possible pathomechanism in disease progression.
    Low HZ; Hilbrans D; Schmidt-Wolf IG; Illges H
    Int J Hematol; 2012 Sep; 96(3):350-6. PubMed ID: 22899340
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Phenotypic analysis of receptor-ligand pairs on B-cells in B-chronic lymphocytic leukemia.
    Gagro A; Dasić G; Sabioncello A; Rabatić S; Reckzeh B; Havemann K; Kardum I; Jacksić B; Vitale B
    Leuk Lymphoma; 1997 Apr; 25(3-4):301-11. PubMed ID: 9168440
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Quantitative expression of CD23 and its ligand CD21 in chronic lymphocytic leukemia.
    Lopez-Matas M; Rodriguez-Justo M; Morilla R; Catovsky D; Matutes E
    Haematologica; 2000 Nov; 85(11):1140-5. PubMed ID: 11064465
    [TBL] [Abstract][Full Text] [Related]  

  • 105. A CD21 low phenotype, with no evidence of autoantibodies to complement proteins, is consistent with a poor prognosis in CLL.
    Nichols EM; Jones R; Watson R; Pepper CJ; Fegan C; Marchbank KJ
    Oncotarget; 2015 Oct; 6(32):32669-80. PubMed ID: 26452134
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Soluble CD21 (sCD21) forms biologically active complexes with CD23: sCD21 is present in normal plasma as a complex with trimeric CD23 and inhibits soluble CD23-induced IgE synthesis by B cells.
    Frémeaux-Bacchi V; Fischer E; Lecoanet-Henchoz S; Mani JC; Bonnefoy JY; Kazatchkine MD
    Int Immunol; 1998 Oct; 10(10):1459-66. PubMed ID: 9796912
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Genetic CD21 deficiency is associated with hypogammaglobulinemia.
    Thiel J; Kimmig L; Salzer U; Grudzien M; Lebrecht D; Hagena T; Draeger R; Voelxen N; Bergbreiter A; Jennings S; Gutenberger S; Aichem A; Illges H; Hannan JP; Kienzler AK; Rizzi M; Eibel H; Peter HH; Warnatz K; Grimbacher B; Rump JA; Schlesier M
    J Allergy Clin Immunol; 2012 Mar; 129(3):801-810.e6. PubMed ID: 22035880
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Serum levels of soluble CD21 in patients with systemic sclerosis.
    Tomita M; Kadono T; Yazawa N; Kawashima T; Tamaki Z; Ashida R; Ohmatsu H; Asano Y; Sugaya M; Kubo M; Ihn H; Tamaki K; Sato S
    Rheumatol Int; 2012 Feb; 32(2):317-21. PubMed ID: 21052675
    [TBL] [Abstract][Full Text] [Related]  

  • 109. CD21low B cells in common variable immunodeficiency do not show defects in receptor editing, but resemble tissue-like memory B cells.
    Rakhmanov M; Gutenberger S; Keller B; Schlesier M; Peter HH; Warnatz K
    Blood; 2010 Nov; 116(18):3682-3. PubMed ID: 21051568
    [No Abstract]   [Full Text] [Related]  

  • 110. B cell receptor-mediated calcium signaling is impaired in B lymphocytes of type Ia patients with common variable immunodeficiency.
    Foerster C; Voelxen N; Rakhmanov M; Keller B; Gutenberger S; Goldacker S; Thiel J; Feske S; Peter HH; Warnatz K
    J Immunol; 2010 Jun; 184(12):7305-13. PubMed ID: 20495065
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Circulating CD21low B cells in common variable immunodeficiency resemble tissue homing, innate-like B cells.
    Rakhmanov M; Keller B; Gutenberger S; Foerster C; Hoenig M; Driessen G; van der Burg M; van Dongen JJ; Wiech E; Visentini M; Quinti I; Prasse A; Voelxen N; Salzer U; Goldacker S; Fisch P; Eibel H; Schwarz K; Peter HH; Warnatz K
    Proc Natl Acad Sci U S A; 2009 Aug; 106(32):13451-6. PubMed ID: 19666505
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Complement receptors CD21 and CD35 in humoral immunity.
    Roozendaal R; Carroll MC
    Immunol Rev; 2007 Oct; 219():157-66. PubMed ID: 17850488
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Redox regulation of CD21 shedding involves signaling via PKC and indicates the formation of a juxtamembrane stalk.
    Aichem A; Masilamani M; Illges H
    J Cell Sci; 2006 Jul; 119(Pt 14):2892-902. PubMed ID: 16803874
    [TBL] [Abstract][Full Text] [Related]  

  • 114. B-cell chronic lymphocytic leukemia, a clonal disease of B lymphocytes with receptors that vary in specificity for (auto)antigens.
    Chiorazzi N; Hatzi K; Albesiano E
    Ann N Y Acad Sci; 2005 Dec; 1062():1-12. PubMed ID: 16461783
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Soluble CD21 in sera and synovial fluid of arthritic patients.
    Grottenthaler T; von Kempis J; Goldacker S; Illges H
    Rheumatol Int; 2006 Jan; 26(3):240-3. PubMed ID: 15770483
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Reduction of soluble complement receptor 2/CD21 in systemic lupus erythomatosus and Sjogren's syndrome but not juvenile arthritis.
    Masilamani M; Nowack R; Witte T; Schlesier M; Warnatz K; Glocker MO; Peter HH; Illges H
    Scand J Immunol; 2004 Dec; 60(6):625-30. PubMed ID: 15584974
    [TBL] [Abstract][Full Text] [Related]  

  • 117. A new CD21low B cell population in the peripheral blood of patients with SLE.
    Wehr C; Eibel H; Masilamani M; Illges H; Schlesier M; Peter HH; Warnatz K
    Clin Immunol; 2004 Nov; 113(2):161-71. PubMed ID: 15451473
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Phenotypic and functional characterization of monocyte-derived dendritic cells in chronic lymphocytic leukaemia patients: influence of neoplastic CD19 cells in vivo and in vitro.
    Orsini E; Pasquale A; Maggio R; Calabrese E; Mauro FR; Giammartini E; Guarini A; Foa R
    Br J Haematol; 2004 Jun; 125(6):720-8. PubMed ID: 15180861
    [TBL] [Abstract][Full Text] [Related]  

  • 119. B cell activation leads to shedding of complement receptor type II (CR2/CD21).
    Masilamani M; Kassahn D; Mikkat S; Glocker MO; Illges H
    Eur J Immunol; 2003 Sep; 33(9):2391-7. PubMed ID: 12938215
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Decreased levels of serum soluble complement receptor-II (CR2/CD21) in patients with rheumatoid arthritis.
    Masilamani M; von Kempis J; Illges H
    Rheumatology (Oxford); 2004 Feb; 43(2):186-90. PubMed ID: 12867574
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.